Ascorbate and Htn - a phase IV clinical study of FDA data

Summary:

Htn is reported as a side effect among people who take Ascorbate (vitamin c (ascorbic acid)), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Actemra, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Htn when taking Ascorbate. It is created by eHealthMe based on reports of 1,412 people who have side effects when taking Ascorbate from the FDA, and is updated regularly.

What is Ascorbate?

Ascorbate has active ingredients of vitamin c (ascorbic acid). eHealthMe is studying from 1,446 Ascorbate users. Check the latest studies of Ascorbate.

What is Htn?

Htn is found to be associated with 3,923 drugs and 5,235 conditions by eHealthMe. Check the latest studies of Htn.

On Apr, 10, 2026

1,412 people reported to have side effects when taking Ascorbate.
Among them, 206 people (14.59%) have Htn.

Among these 206 people:

How long have people been on Ascorbate when they have Htn? *

What is the gender of people who have Htn when taking Ascorbate? *

female: 79.73 %
male: 20.27 %

What is the age of people who have Htn when taking Ascorbate? *

What are other drugs people take besides Ascorbate? *

Actemra: 153 people, 74.27%
Cetirizine Hydrochloride: 130 people, 63.11%
Vitamin C: 126 people, 61.17%
Prednisone: 122 people, 59.22%
Acetaminophen: 119 people, 57.77%
Xeljanz: 119 people, 57.77%
Enbrel: 117 people, 56.80%
Humira: 113 people, 54.85%
Folic Acid: 112 people, 54.37%
Hydroxychloroquine Sulfate: 112 people, 54.37%

What are other side effects people have besides Htn? *

Joint Swelling: 135 people, 65.53%
Infusion Related Reaction: 134 people, 65.05%
Drug Ineffective: 132 people, 64.08%
Joint Pain: 132 people, 64.08%
Hepatic Enzyme Increased: 125 people, 60.68%
Drug Intolerance (drug sensitivity): 124 people, 60.19%
Pain: 123 people, 59.71%
Dizziness: 121 people, 58.74%
Diarrhea: 118 people, 57.28%
Fatigue (feeling of tiredness): 117 people, 56.80%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 143 people, 69.42%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 96 people, 46.60%
Migraine (headache): 81 people, 39.32%
Psoriasis (immune-mediated disease that affects the skin): 75 people, 36.41%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 41 people, 19.90%
Stress And Anxiety: 23 people, 11.17%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 20 people, 9.71%
Herpes Zoster: 20 people, 9.71%
Pain: 19 people, 9.22%
Indigestion: 12 people, 5.83%

* Approximation only. Some reports may have incomplete information.

Do you take Ascorbate and have Htn?

- Check whether Htn is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ascorbate:

Ascorbate (1,446 reports)

Htn treatments and more:

Htn (1,062,831 reports)

Browse all side effects of Ascorbate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Htn:

Htn (3,923 drugs)

Browse all the conditions that are associated with Htn:

Htn (5,235 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vitamin c (ascorbic acid) (the active ingredients of Ascorbate) and Ascorbate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.